1.
Investigations Branches a) Consumer adverse events or complaints, and trade complaints should be entered in FACTS. FDA Field Offices should handle cosmetic problems and emergencies on a case by case basis depending on the severity of the situation. However, since FACTS entries must be closed out before they can be downloaded into CFSAN's adverse event database, CAERS, there can be a significant length of time before FDA headquarters or the Office of Cosmetics and Colors might be informed of an unusual event. Therefore, in case of an unusual or high priority situation involving a cosmetic product, please contact the Office of Emergency Operations (OEO) at 301-796-8240 (24 hours) or email emergency.operations@fda.hhs.gov to report the situation (in addition to data entry into FACTS).
b) Within 30 days after completion of each inspection, electronically submit into CMS to HFS-608, CFSAN/OC/DE/Labeling and Dietary Supplement Branch, the following items: 1) a copy of the "Summary of Findings" for each inspection 2) a copy of the vendor/supplier list collected for each inspection.
Laboratory Branches
Report all analyses into the Field Accomplishment and Compliance Tracking System (FACTS) using the following Problem Area 
SPECIAL INSTRUCTIONS

General
Routine domestic and/or import sample collections/analysis for COL or MIC should take place as per the current fiscal year (FY) SCOPE.
Collect cosmetic samples under this program on a "for cause" compliance basis to support and document inspectional evidence of suspected adulteration and/or misbranding only. Concentrate on the following four areas:
• Collect product samples for color analysis and prohibited ingredients.
• Collect samples of labeling to document suspect labeling violations.
• Collect samples of eye area cosmetics, tattoo inks or skin care preparations and lotions for microbiological analysis when adequate challenge test documentation cannot be produced, the adequacy of preservation is in doubt or non-traditional preservative systems are used.
• Collect samples of cosmetic products for screening of prohibited elements, as directed by CFSAN assignment.
Report only COSMETIC import label exams, inspections, sample collections under this program.
Domestic
Conduct routine surveillance inspections only at firms manufacturing or repacking eye area cosmetics, tattoo ink, skin care preparations and lotions, non-alcohol oral care products, and products intended for use by and on infants and children. These products present the greatest potential health hazard if they become contaminated with bacteria and fungi. However, once in the firm, conduct review of cosmetics according to instructions provided in Part III of this program.
Imports
In accordance with instructions provided in Part III of this program, import label examinations should emphasize four primary areas:
• review for compliance with mandatory labeling requirements, including, but not limited to, required warning statements; • prohibited or restricted ingredients • non-certified and non-permitted color additives; and • Cosmetics containing bovine-derived tissues imported from BSE affected or at-risk countries.
The cosmetic industry is undergoing rapid technological changes, the manufacturing base becoming more global, and the ingredients ever more diverse. For some of these ingredients, there is little information available to substantiate safety. Ingredients, including nano-based chemicals, which may be subject to stringent drug and/or food pre-approval processes, are often incorrectly introduced into U.S. commerce through the cosmetic market due to its low regulatory barriers and may be cause a cosmetic to be adulterated if the safety of the ingredient has not been established.
Another change that the cosmetics industry is facing is consumer distaste for traditional preservatives. As an example, parabens, which are one of the most effective classes of preservatives, have been suspected of causing adverse effects to the endocrine system. In the European Union parabens are being phased out of all cosmetics because of this concern. As a result manufacturers are applying non-traditional preservative systems in order to assure the microbial safety of their products. FDA is concerned that cosmetic products that make a statement in labeling that the product is "green", "natural", "no parabens" and "no preservatives" may not be safe for consumers without appropriate safety testing. Companies and products that make such label statements should be given priority over traditionally manufactured cosmetics during inspection and sampling.
Adverse events have been associated with a variety of cosmetic products for several reasons including the following:
• color additive violations • sensitivities to specific ingredients or the product formulation • microbial contamination • product misuse due to inadequate labeling Surveillance of high risk cosmetics is a useful tool for identifying safety concerns related to a marketed product. Serious adverse events may warrant an inspection and/or sample collection. Examples of high risk cosmetic products that have been associated with serious adverse events include low-or noalcohol mouthwash, eye area cosmetics, tattoo inks including permanent makeup, hair straighteners, and seasonal products (e.g. face paints and tanning products, which may be reported more frequently in the fall and summer seasons, respectively).
FDA has received reports from consumers, health care professionals, and salon experts that associate a loss of vision with the use of contaminated eye area cosmetics; rashes with the use of contaminated face paints; and local and systemic infections with the use of tattoo inks, all of which being contaminated with pathogenic microorganisms. FDA has also received reports of adverse events involving hair straightening products caused by product misuse due to inadequate labeling. Labeling may lack a clear statement of the intended use of the product, warning statements, and directions for safe use.
Some cosmetics are labeled as "professional use only" products, which require a trained and/or licensed professional to apply the cosmetic. Examples include hair straighteners and tattoos. Although FDA regulates cosmetic products, the facilities where these products are used, as well as the specific practices employed, are regulated by local and state authorities. FDA consults with the Occupational Safety and Health Administration (OSHA) and other regulatory agencies as appropriate.
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PART II -IMPLEMENTATION
Objectives
To ensure that imported and domestic cosmetics meet regulatory requirements through inspection, sample collection and analysis.
Program Management Instructions
Interaction with other compliance programs 
Planning Instructions
Cover only cosmetics (see Part III, Section 1, for instructions in determining whether a product is a cosmetic, a drug, or a drug as well as a cosmetic).
Select firms for inspection in the following order of priority:
a) Manufacturers who have recalled cosmetics because of microbial contamination during the previous 3-year period; b) Manufacturers of high-risk products that have had an OAI or VAI inspection within the previous 3-year period. High-risk products include:
1. eye area cosmetics 2. cosmetic non-alcohol oral care products 3. wet wipes used by infants or children 4. tattoo ink 5. skin care preparations and lotions c) Firms that manufacture/repack high-risk products and firms that have serious Adverse Event reports or are manufacturers of recalled products. Refer to your district's cosmetic Official Establishment Inventory (OEI) to select these firms. To aid the districts in selecting firms, CFSAN will provide an inventory of firms that have been determined to be producing high-risk products. Use the firms provided on CFSAN's list to supplement OEI inspections.
d) Any routine cosmetic surveillance inspection under this Compliance Program should be made only at firms' manufacturing or repacking locations.
PART III -INSPECTIONAL
A. General
The instructions in the program apply to cosmetics only. To determine if a product should be covered under this program, refer to its list of ingredients. The product should be covered as a cosmetic if no "active ingredient" is declared and there are no indications of intended drug use (i.e., labeling claims, promotional statements, etc.). If the product is determined to be a drug, it should not be covered under this program.
CDER and CFSAN have agreed to have concurrent jurisdiction, to assist FDA in implementing the cosmetic and drug provisions of the FD&C Act by clarifying program responsibilities in light of overlapping jurisdiction between CDER and CFSAN. Under this agreement, CDER and CFSAN have concurrent jurisdiction over a product which purports to be a cosmetic but meets the definition of drug. Both CDER and CFSAN may bring regulatory action relating to such product. CFSAN will not include drug charges in any such action without first notifying CDER of the charges that will be included. CDER will not include cosmetic charges in such an action without first obtaining CFSAN's concurrence.
In general, FDA does not have limits on elements allowed in cosmetics, with a few exceptions. When suspect cosmetics are identified, CFSAN/OCAC should be consulted prior to initiating further regulatory action, including sampling and testing.
B. Inspections
General guidelines for the areas to be covered during activities conducted under this program can be found in the document entitled "Cosmetic Good Manufacturing Practice Guidelines" (http://www.fda.gov/Cosmetics/GuidanceRegulation/GuidanceDocuments/ucm35 3046.htm). Items covered under this program include building and facilities, equipment, personnel, raw materials, production, laboratory controls, records labeling and complaints.
Note: Additional background information concerning topics related to cosmetics may also be found on the FDA Cosmetic website (http://www.fda.gov/Cosmetics/default.htm).
The following additional items should be covered during inspections of cosmetic manufacturers under this compliance program:
Cosmetics Making Drug Claims (DOMESTICS AND IMPORTS)
If product labels, packaging and inserts appear to make claims that would cause the product to be a drug, the labeling should be collected and submitted to the District Compliance Branch for evaluation. For general information on the differences between cosmetics and drug products, see "Is It a Cosmetic, a Drug, or Both? (Or Is It Soap? General information on reviewing product labels for cosmetic products can be found at the Summary of Labeling Requirements website (http://www.fda.gov/Cosmetics/Labeling/Regulations/ucm126438.htm).
Prohibited/Restricted Ingredients (DOMESTICS AND IMPORTS)
By examination of labels for finished products and raw materials, determine whether any of the following prohibited or restricted ingredients are being used by the firm in the production of cosmetic products. Examination of batch records if provided, and other documents (e.g. product formulations, certificates of analysis), may also provide useful information. If these ingredients do not appear in any of the documents, query the firm directly.
Prohibited (Non-Permitted) Ingredients Refer to 21 CFR 700.27 for more information, particularly for more information on the definition for cattle "inspected and passed" and a process for foreign countries to be exempted from provisions regarding prohibited cattle material.
A current listing of countries designated for exemption under paragraph (e) of 21 CFR 700.27 may be obtained from CFSAN OFS (Jeffrey Hamer (240)402-4188, or Jeffrey.Hamer@fda.hhs.gov).
BSE Record Keeping Requirements:
In accordance with 21 CFR 700.27(c), manufacturers and processors of a cosmetic that is manufactured from, processed with, or otherwise contains, material from cattle must establish and maintain records to demonstrate that the cosmetic is not manufactured from, processed with, or does not otherwise contain, prohibited cattle materials. These records must be retained for 2 years at the manufacturing establishment or at a reasonably accessible location. Electronic records are acceptable if they are accessible from an onsite location.
These records must be available to FDA for inspection and copying.
Product labels and cosmetic raw materials, bulk cosmetic formulations, and finished cosmetic products and relevant records should be reviewed to determine if any of the products or ingredients contain prohibited cattle material.
If a firm manufacturing or importing cosmetic products or their ingredients uses any prohibited cattle material, document the following:
• The finished products containing the prohibited tissue • The specific country of origin of the tissue • The name and address of the importer or other responsible party. Note: FDA labs do not conduct BSE analysis and thus no sampling guidance is issued for BSE. The basis for any regulatory action on a cosmetic product with respect to prohibited cattle material relies on review of records as described above, labeling and other documentation.
Adequacy of Preservation (DOMESTICS)
Numerous factors can influence a products susceptibility to microbial contamination. The choice of preservative system is important, along with other factors. In some instances, such as products dispensed from pressurized containers, there may be no need for added preservatives.
As appropriate, review the manufacturer's records and determine the identity and level of preservatives intended for each formulation. (See Attachment C "Preservation Systems for Cosmetics" for lists of common cosmetic preservatives, non-traditional preservatives and other considerations in evaluating a preservative system.) Verify that batch records indicate the addition of these preservatives to each formulation.
The susceptibility of a product to microbial contamination is often For a complete listing and permitted uses of each color additive approved for use in cosmetics, refer to "Color Additives Permitted for Use in Cosmetics" (http://www.fda.gov/Cosmetics/Labeling/IngredientNames/ucm109084.htm).
Click on the "CFR Section Number" on the right-hand side to view the actual regulation, including uses, specifications, and restrictions for each color additive.
Investigators should perform a label review of finished cosmetic products. Ensure that all color additives are listed on the product label, and that those being declared in the product as ingredients are permitted for use in that product type and that they are otherwise being used in conformance with the specifications in the listing regulations. Investigators should pay particular attention to color additives used in cosmetics intended for the area of the eye (see 21 CFR 70.3(s) for a definition of "area of the eye") as there are only a limited number that are specifically permitted by regulation for use in eye area cosmetics.
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Special Considerations for Color Additives Subject to Certification: (DOMESTICS AND IMPORTS)
Certifiable color additives, sometimes referred to as "synthetic-organic colors" must undergo batch testing by FDA. This process, known as color additive certification, assures the safety, quality, consistency and strength of the color additive prior to its use in cosmetics. Part 74, Subpart C and Part 82, Subparts B and C list the color additives permitted in cosmetics which are subject to batch certification. When FDA certifies a batch of bulk color additive, the color additive manufacturer is assigned a unique, six-digit lot number, beginning with two alpha characters followed by four number characters (e.g. XX1234).
Finished-product manufacturers must ensure that they purchase certified color additives labeled with the batch certification lot number from color additive manufacturers.
Investigators may encounter certified color additives as raw material or as an ingredient listed on a product label. Each color additive included in a cosmetic product must be included in the product declaration of ingredients (using either the listed or abbreviated name e.g., Ext. D&C Yellow No. 7 or Ext. Yellow 7). Laboratory analysis of a cosmetic cannot determine whether a lot of color additive used was certified; therefore, investigators should ask manufacturers to provide FDA certification lot number(s) for color additives used in cosmetic products. Check the authenticity of each certification lot number by accessing FDA's Color Certification database (http://inside.fda.gov:9003/CFSAN/OfficeofCosmeticsandColors/ucm406788.h tm)and keying in the six-digit lot number in the character field.
The information returned from the site includes: -the name of the certified color additive -the batch certification number of the original color additive that was manufactured -the name of the company associated with the certified color additive -the certification date (Note: First time database users will be directed to click on the "Request Access" box for verification; permission is granted via email.)
In the case of color additive mixtures, the label should declare a control number that can be traced to the FDA certification lot number of the color additives present in the mixture.
Cosmetic Product Labeling Requirements-Ingredients (DOMESTIC AND IMPORTS)
Examine the declaration of ingredients on all cosmetic products intended for sale to consumers to determine compliance with 21 CFR 701.3. Note that products that are used only in salons and not sold to consumers (usually labeled "For Professional Use Only") or free samples where another purchase is not required to receive the free sample, are not required to bear an ingredient declaration under the FPLA (Section 1459). If, however, these products are customarily sold to consumers for their personal use, they are not exempt from ingredient labeling requirements and must bear an ingredient statement.
As the cosmetic marketplace has become more global, certain situations now arise with greater frequency and should receive special attention:
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Use of a language other than English -All words, statements, and other information required by or under authority of the FD&C Act to appear on the label or labeling shall appear in the English language (except in the case of products distributed solely in Puerto Rico or in a U.S. Territory where the predominant language is other than English). If the label or labeling also contains any representation in a foreign language, then all words, statements, and representations must be made in that language. For color additives, FDA does not object to C.I. numbers being used in a dual declaration with the official FDA-sanctioned name, provided all of the requirements of the relevant color additive regulations have been met and the FDA-sanctioned name is listed first. An acceptable dual declaration will list the FDA-sanctioned name first followed by the C.I. number in parentheses.
Example:
The Agency also does not object to a similar type of dual declaration for botanical ingredients where both the Linnaean taxonomic (genus/species) name and English "common or usual name" are listed, provided that the English "common or usual name" is listed first. Example: Dandelion Leaf Extract (Taraxacum officinale Leaf Extract)
If there is no English "common or usual name" for a botanical ingredient, FDA does not object to the Linnaean name being used alone, per 21 CFR 701.3(c) (4 
Directions for Safe Use (DOMESTICS AND IMPORTS)
Products described below are known to produce adverse reactions in individuals when not properly formulated or when improperly used by the consumer.
The firms' labeling of the products below warrants close attention during cosmetic inspections. Adequate instructions for use must be provided, including, but not limited to, any necessary time limits on application, instructions for washing off, or patch tests on small areas of the body, as appropriate. Questions about the adequacy of use instructions should be referred to CFSAN's Office of Cosmetics and Colors at 240-402-1130.
• Depilatories and hair straighteners;
• Permanent wave neutralizers;
• Nail builders, hardeners, and enamels;
• Artificial or sculptured fingernail glue; and • Coal tar hair dyes (Under section 601 (a) the label must bear instructions for preliminary patch testing for possible skin irritation)
Cosmetic Product Packaging Requirements (DOMESTIC AND IMPORTS)
Determine whether cosmetic liquid oral hygienic products and all cosmetic vaginal products intended for retail sale comply with tamper-resistant packaging requirements and assure that the product label bears the statement alerting consumers to the tamper-resistant features (21 CFR 700.25).
Field Exam and/or Document Review (IMPORTS)
Note: Districts must refer to the FDA Import Alerts and active bulletins in the Compliance Management System for import alerts and bulletins for cosmetic products.
ORA includes resources for conducting label examinations of import entries under this program. Each label examination should cover five (5) focal areas:
1. Cover cosmetics only. (See Part I "Background," and Part III "Inspectional", Section 1. "General" in this Cosmetic Program Guidance Manual, for instructions in determining whether a product is a cosmetic, a drug, or drug as well as cosmetic. A listing of cosmetic product categories can be found at 21 CFR 720.4(c));
2. Include a review to ensure the product complies with mandatory labeling and packaging requirements, including required warning statements; prohibited/restricted ingredients; and non-certified or non-permitted color additives utilizing the instructions provided above under Part III, "Inspections";
3. Include a review of cosmetic labels with added "ingredient stickers" signifying possible re-labeling of a brand name (so called "gray market cosmetics" produced for markets outside of the U.S.) Cosmetics formulated for use in other countries may contain color additives not permitted in the U.S. When performing a field exam, please review Part III, Section 4, "Color Additives" for instructions in determining whether a product may contain non-certified or non-permitted color additives.
In addition, if the label of an imported cosmetic identifies color additives with their European name or ("E") color designation with a corresponding number (e.g., E104, E122, E123, and E124), a color index number (e.g., C.I. 15985) or the trade name of the color additive (e.g., Sunset Yellow FCF) alone without the U.S. approved designation, this suggests that the color additive used may not be certified or permitted. In these situations, districts should consider detaining without sampling based on the appearance of adulteration (i.e., the product appears to contain an uncertified color additive). These situations can be processed in OASIS using a violative label exam (Work Type LEX).
If the imported product appears to contain undeclared color additives, product samples should be obtained and sent to the designated laboratory for color analysis. 11. Alpha Hydroxy Acids (AHAs) "Sunburn Alert" AHA Labeling Statement (DOMESTICS AND IMPORTS)
Because of the potential for increased sensitivity to the sun, manufacturers must use the following guidance labeling statement for topically applied cosmetic products containing AHAs (e.g., glycolic acid, lactic acid) as ingredients Sunburn Alert: This product contains an alpha hydroxy acid (AHA) that may increase your skin's sensitivity to the sun and particularly the possibility of sunburn. Use a sunscreen, wear protective clothing, and limit sun exposure while using this product and for a week afterwards.
Investigators are requested to notify firms manufacturing cosmetics containing AHAs of "Guidance for Industry: Labeling for Topically Applied Cosmetic Products Containing Alpha Hydroxy Acids as Ingredients" (http://www.fda.gov/Cosmetics/GuidanceRegulation/GuidanceDocuments/ucm09081 6.htm). 
C. Sample Collections
For cosmetic color additive samples, consult Chapter 4 of the current edition of the IOM (Chart 9), "Sample Schedule for Color Containing Product, Color Additive" (https://www.fda.gov/downloads/ICECI/Inspections/IOM/UCM123507.pdf).
Note:
Bulk color additives that are used as cosmetic ingredients should be collected under Industry Code 50. For straight colors, collect 28 gm (1 oz.) of powder. For color mixtures, collect 100 gm (4oz.) of liquid, paste or powder. If the color mixture contains over 50% pure dye, collect 55 gm (2oz.).
Color additive samples of finished cosmetics should be collected under Industry Code 53. If the product is strongly colored (e.g., lipsticks, hair coloring, products, eye mascara, eye liner, make-up, pencils of all types) collect four retail packages of the same lot code for each shade (color) in the product line. If the product is lightly colored (e.g., creams, lotions, shampoos, bath products, shaving preparations and perfumes), collect a sufficient number of retail packages to equal 1 lb (dry) or 1 pt (liquid) of sample. Always collect a minimum of two retail units of each product.
For bulk cosmetic products, collect samples for color additive analysis in the following quantities:  Dry 454 gm (1 lb.);  Liquids -Minimum of 36 fl. oz.
DOMESTICS:
For microbiological analysis, collect samples of eye area cosmetics, tattoo inks or skin care preparations and lotions when adequate challenge test documentation cannot be produced, the adequacy of preservation is in doubt or non-traditional preservative systems are used.
If uncertain whether to collect a sample, contact the appropriate CFSAN regulatory contact listed in Part VI of this program for additional instructions.
IMPORTS:
If product packaging and labeling indicates that a violation of the Act may exist, the field should collect samples to support potential regulatory action. The collected samples should be sufficient to ensure that the regulatory action is supportable. If the apparent violation is for micro contamination, undeclared colors, or heavy metals, etc. a physical sample and laboratory analysis would be appropriate.
Bulk
One (1) 100 gm (4 oz) subsample from each of ten containers Note: In the absence of specific sampling instruction for tattoo ink, contact the Program Analytical Contacts for guidance on adequate sample sizes.
Imports
All import lines sampled under this program must be held pending analysis. For entries that contain multiple lines of different product types that were not evaluated, the additional lines can be released if they do not appear to be violative.
SAMPLE SHIPMENT
Submit samples to your district's analytical laboratory or specialized CFSAN laboratory as appropriate to conduct the intended analysis as indicated in PART IV, Section A.
Important Note: For samples collected for field lab analysis, refer to the Servicing Laboratories section of the ORA Field Workplan. For this reason, for each type of analysis to be performed by CFSAN, a contact person is provided in Part IV, Section B. Collecting districts should contact that person by email to confirm the shipping address prior to shipping any samples to CFSAN. For CFSAN, refer to CFSAN contact list. Tables are being used as an alternative system to the National Sample Distributer (NSD). However, if a specific laboratory has been indicated in a sampling assignment then that laboratory should be referenced during the C/R preparation process. 
Servicing Laboratory Tables
B. ANALYSIS a) Microbiological
All method references to the e-BAM refer to the current edition of the Bacteriological Analytical Manual (https://www.fda.gov/Food/FoodScienceResearch/LaboratoryMethods/uc m2006949.htm).
Refer to the e-BAM, Chapter 23 for methods to determine microbial contamination of cosmetics, except tattoo ink.
Tattoo ink and materials used to manufacture tattoo ink should be sent to Pacific Regional Lab (PRL-SW) for analysis. For the analysis of tattoo ink, refer to an appropriate validated method such as http://inside.fda.gov:9003/downloads/PolicyProcedures/Laboratories /LaboratoryInformationBulletins/UCM413090.pdf.
All Gram-positive and Gram-negative microbial isolates from aerobic plate counts or enrichments are to be identified to genus and species level using e-BAM, chapter 23 methods and commercial identification systems such as Vitek. Report analytical results into FACTS using the following Problem Area Flags (PAF):
• Use PAF "COL," for non-permitted color additives and identify the non-permitted color additives found.
• Use PAF "MIC," for microbiological examinations and identify the microorganisms(s) and level.
• Use PAF "ELE" for toxic elements
• Use PAF "FDF," Result Flag "FDL" for label reviews (Food Economics and Standards) and identify specific violation(s) found. The receipt of a large number of adverse event reports for a particular product and/or adverse events involving severe chemical burns or severe eye injuries may also be indicative of a potential health hazard situation.
b) If a product presenting a potential health hazard has been distributed.
c) Cosmetic products are not expected to be aseptic; however, they must be completely free of high-virulence microbial pathogens, and the total number of microorganisms per gram must be low. CFSAN is currently using the following level of concern for aerobic plate counts (APCs):
• For eye-area products, counts should not be greater than 500 colony forming units (CFU)/g; • for non-eye-area products, counts should not be greater than 1000 CFU/g. Some examples of bacterial and fungal pathogens or opportunistic pathogens whose incidence would be of particular concern, especially in eye-area cosmetic products, include Staphylococcus aureus, Streptococcus pyogenes, Pseudomonas aeruginosa, Aspergillus sps, Candida albicans, Klebsiella pneumoniae, and other species.
The list of microorganisms noted above is not all-inclusive. When determining the pathogenicity of a specific microorganism and the potential health risk to consumers as a result of its presence in a cosmetic product, OCAC microbiologists consider several factors. Evidence in the available literature regarding cases of infection in healthy populations without intervening factors such as prior surgery or compromised immune systems is of primary significance. Mode and frequency of product application and container design, among other factors, are also taken into consideration when evaluating potential risk to the consumer. For example, some organisms are capable of causing eye diseases in healthy individuals when the eye, or area around the eye, is punctured or abraded. Questions regarding the pathogenicity and potential health risks of a given microorganism in a specific type of cosmetic product should be referred to CFSAN. In addition, OCAC recognizes that the skin and ocular surface of healthy individuals inherently supports a moderate population of bacteria, typically coagulase-negative staphylococci (CNS), which are believed to exist as commensals. Under normal conditions, in healthy individuals, there is little or no opportunistic microbial colonization and infection resulting from these commensals, such as Staphylococcus epidermidis, Staphylococcus hominis, and Micrococcus luteus. As long as the overall microbial population in a cosmetic product is below regulatory limits, the sole presence of commensal microorganisms does not pose a significant health risk and does not render the product adulterated.
If a cosmetic appears to be making drug claims:
CDER and CFSAN have agreed to have concurrent jurisdiction to assist FDA in implementing the cosmetic and drug provisions of the FD&C Act by clarifying program responsibilities in light of overlapping jurisdiction between CDER and CFSAN. Under this agreement, CDER and CFSAN shall have concurrent jurisdiction over a product which purports to be a cosmetic but meets the definition of drug. Both CDER and CFSAN may bring regulatory action relating to such product. CFSAN will not include drug charges in any such action without first notifying CDER of the charges that will be included. CDER will not include cosmetic charges in such an action without first obtaining CFSAN's concurrence.
Districts may submit recommendations for advisory (e.g., Warning Letter) or enforcement action to CFSAN, and CFSAN will coordinate the action with CDER.
e) Contact CFSAN/OC/DE/ Labeling and Dietary Supplement Compliance Branch (HFS-608) if necessary for assistance when an import shipment is detained in accordance with I.A. #17-04 for bulk shipments of high-risk bovine tissues and tissue-derived ingredients.
If a cosmetic product contains or appears to contain prohibited cattle material, it should be detained. In order to obtain release of the product, the importer should provide records sufficient to demonstrate that the cosmetic is not manufactured from, processed with, or does not otherwise contain, prohibited cattle material. Examples of documents that may be useful to the reviewer in making a determination include: 
Direct Reference Seizure Authority
Updated instructions regarding direct reference seizure authority for Pseudomonas aeruginosa contamination of cosmetics used in the eye area may be found in Section 590.300 of the Compliance Policy Guide Manual (CPG). The specimen charge is stated in the CPG.
SPECIMEN CHARGE:
The article (was adulterated while introduced into and while in interstate commerce) or (is adulterated while held for sale after shipment in interstate commerce) within the meaning of the Act, 21 U.S.C. 361(a) in that it contains a poisonous or deleterious substance, Pseudomonas aeruginosa, which may render it injurious to users under such conditions of use as are customary or usual.
Complete labeling and worksheets must accompany direct seizure recommendations when forwarded to the Office of Chief Counsel through the Division of Enforcement in the Office of Enforcement and Import Operations (HFC-210).
Seizure with Center Review
All other cases must be submitted to the Center for Food Safety an Applied Nutrition (CFSAN) through the electronic MARCS-CMS system. MARCS-CMS is a collection of modules supporting Agency compliance management and work flow for compliance-related activities. MARCS-CMS provides the mechanism to electronically send this information to the appropriate organizational unit based on individual organizations' business practices. It also provides the means to associate all evidence needed to support the Compliance Action. This evidence may contain enforcement, precedent scientific, or interpretive information relating to the Compliance Action.
Users can access the system by navigating through INSIDE.FDA.GOV. From this screen select MARCS-CMS link. A user's Guide is available within the application under the User's Guide link located at the top of the MARCS-CMS Main Screen.
If any of the situations below are encountered for domestic products, and the firm involved does not voluntarily recall all of the affected products districts should submit a recommendation for seizure (including sample analyses), electronic copy (e.g., .doc, .pdf files, etc. • Prohibited as ingredients of cosmetic aerosol products:
i. vinyl chloride (21 CFR 700.14); and ii.
zirconium (21 CFR 700.16).
• Restricted ingredients of cosmetic products unless used as specified in the regulations: • This article may also be misbranded within the meaning of section 1454(c) (3) • Appropriate Cautionary Statements and Directions for Safe Use.
The following products may be deemed adulterated or misbranded if the labeling does not contain an appropriate warning statement(s) and/or directions for safe use (see the appropriate section of the Act in parentheses):
i. Depilatories and hair straighteners (Section 602(a) of the Act);
ii. • Sun-tanning Products These products may be drugs and/or cosmetics, depending on the claims. If the product labeling includes any of the following claims, the product will be regulated as a drug:
i.
The labeling bears any direct or implied statement that the product screens out ultraviolet sunlight, prevents or treats sunburn, prevents wrinkles, or prevents premature aging of the skin; ii.
The label bears a number representing the sun protection factor (SPF) value; or iii.
The sunscreen ingredient is declared as an active drug ingredient and is listed before the listing of the cosmetic ingredients -Section 502(e)(1) of the Act and 21 CFR 701.3(d).
Suntan cosmetic products that do not contain a sunscreen must bear adequate directions for safe use and the warning statement required under 21 CFR 740.19. If the products do not comply with the regulation, they are misbranded under Section 602(a) of the Act.
There are "tanning pills" manufactured as capsules intended for ingestion. These products usually contain beta carotene and/or canthaxanthin. They act by entering the blood stream and are partially deposited in skin tissue, giving the skin a tan-like color. Neither beta carotene nor canthaxanthin is approved for this use, and tanning pill products containing these color additives are considered adulterated under Section 601(e). (NOTE: "Suntan accelerators" are new drugs within the meaning of Section 201(p) of the Act).
• Cosmetics Containing Sunscreen Ingredients
These products may contain a sunscreen ingredient for purposes other than sun protection (e.g., as a color additive or to protect the color of the product). Such products are required to be labeled with qualifying information in conjunction with the term "sunscreen" or other similar protection terminology used in the • Cosmetics packaged in self-pressurized containers Cosmetic aerosol products are misbranded unless the labeling bears the label statements required for cosmetics in self-pressurized containers (21 CFR 740.11, Sections 602(a) and 201(n) of the Act).
• Children's foaming detergent bath products Such products (e.g., bubble bath products) are misbranded unless the labeling bears adequate directions for safe use and precautionary statement (21 CFR 740.17, Sections 602(a) and 201(n) of the Act).
• Feminine deodorant sprays Such products are misbranded unless the labeling bears explicit warnings and directions for safe use (when applicable) (21 CFR 740.12, Section 602(a) of the Act). Additionally, these products may be considered misbranded under Sections 602(a) and 201(n) if the labeling contains the word "hygiene" or a similar word. If the product is represented to have a medical usefulness, it may be considered a drug and would be misbranded under Section 502(a) (21 CFR 740.12).
• Tamper Non-traditional preservatives are typically extracts of botanicals, organic acids, alcohols and glycerols. Fermentation products are also used as preservatives. The presence of these types of chemicals in a cosmetic, in the absence of traditional chemicals, indicates they may be used a part of a preservative system. This list is a small sample. 1. Appropriate packaging -Is product packaging and closure consistent with the preservative system of the product? For example, a product dispensed with a pump, a container with a flip cap, or a single use container would require a much less vigorous preservative system than a product in a wide mouth jar or mascara that the consumer can contaminate with every use. 2. Water activity -Products such as powders with little or no water do not require as strong a preservative system as aqueous emulsions.
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Food and Drug Administration, Office of Cosmetic and Colors FACT SHEET FOR COSMETIC MANUFACTURERS, PACKERS AND DISTRIBUTORS
This fact sheet provides answers to some frequently asked questions and lists some useful Web resources.
For more information, please visit FDA's homepage at www.fda.gov. You can access Cosmetics from the list in the upper right-hand corner, or go directly to the Cosmetics home page (http://www.fda.gov/Cosmetics/default.htm). You can access Color Additives resources by going to the A-Z Subject Index, selecting "C," and scrolling down to Color Additives, or going directly to the Color Additives page (http://www.fda.gov/ForIndustry/ColorAdditives/default.htm).
Are cosmetics regulated by FDA?
Yes. For information on FDA's regulation of cosmetics, see "FDA Authority Over Cosmetics" http://www.fda.gov/Cosmetics/GuidanceRegulation/LawsRegulations/ucm074162.htm "Inspection of Cosmetics" http://www.fda.gov/Cosmetics/ComplianceEnforcement/ComplianceResources/ucm136455.htm When is a cosmetic considered a drug?
Some products perceived by consumers to be cosmetics may also be drugs if, in addition to their cosmetic function, they are intended to cure, mitigate, treat or prevent disease, or to affect the structure or any function of the human body (see the definition of a "drug" in section 201(g)of the FD&C Act). Some products can be both a drug and cosmetic, in which case, the product must comply with both the drug and cosmetic regulations. Typical examples of drug/cosmetic claims are: antiperspirant/deodorant products; sunscreen/suntan products; fluoridated toothpaste/toothpastes; antidandruff shampoos/cleansing beautifying shampoos; an SPF claim on a moisturizer or other cosmetics. Resources are listed under Bovine Spongiform Encephalopathy (BSE): http://www.fda.gov/cosmetics/productsingredients/potentialcontaminants/ucm136786.htm
